Posted on 1/31/2016
Using clinical data collected over the past decade through a U.S. cancer registry, researchers at the University of California, San Diego School of Medicine demonstrated that significant strides have been made in improving the survival of adult patients with low-grade gliomas, a slow-growing yet deadly form of primary brain cancer. The findings are published July 1 by Neuro-Oncology: Clinical Practice.
Because of the rarity of low-grade gliomas, the disease remains understudied. The optimal management strategies for these tumors also remain controversial. Decisions of when and whether to administer radiation, what type of surgery to perform, and what type of chemotherapy to use, if any, varies widely among physicians.
"An understanding of how our treatments affect t...